Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
353.16
324.93
349.39
336.81
288.48
248.96
305.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
353.16
324.93
349.39
336.81
288.48
248.96
305.73
Raw Material Cost
174.35
151.99
187.86
160.44
149.39
152.83
144.67
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
20.07
18.58
14.59
19.34
14.05
14.97
12.85
Selling and Distribution Expenses
54.16
47.82
75.52
60.21
45.11
48.50
70.93
Other Expenses
2.42
9.49
6.78
5.27
5.60
4.00
6.63
Total Expenditure (Excl Depreciation)
272.77
313.31
345.82
292.71
264.51
256.33
294.78
Operating Profit (PBDIT) excl Other Income
80.39999999999999
11.6
3.5999999999999996
44.1
24
-7.4
10.9
Other Income
5.57
4.50
13.84
11.03
5.27
11.81
17.81
Operating Profit (PBDIT)
122.59
58.82
40.74
93.91
64.59
44.07
43.14
Interest
20.07
18.58
14.59
19.34
14.05
14.97
12.85
Exceptional Items
16.14
2.59
12.27
-0.07
-0.14
1.72
-6.71
Gross Profit (PBDT)
178.81
172.95
161.53
176.37
139.09
96.13
161.06
Depreciation
45.61
45.61
42.20
42.20
41.60
41.60
32.46
Profit Before Tax
73.05
-2.78
-3.77
32.30
8.79
-10.79
-8.88
Tax
9.49
-12.98
-14.07
-2.29
0.53
-7.21
-5.38
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
49.64
9.29
4.19
33.15
4.21
12.96
11.76
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
49.64
9.29
4.19
33.15
4.21
12.96
11.76
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
5.34
0.21
1.37
-3.42
2.10
-17.62
-17.25
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
54.98
9.50
5.57
29.73
6.31
-4.66
-5.49
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,052.33
2,530.32
2,521.17
2,448.04
2,474.32
2,501.62
2,394.65
Earnings per share (EPS)
0.11
0.02
0.01
0.08
0.01
0.03
0.03
Diluted Earnings per share
0.11
0.02
0.01
0.08
0.01
0.03
0.03
Operating Profit Margin (Excl OI)
20.22%
2.68%
-4.38%
12.08%
6.14%
-3.75%
-2.33%
Gross Profit Margin
33.6%
13.18%
11.0%
22.12%
17.47%
12.38%
7.71%
PAT Margin
14.06%
2.86%
1.2%
9.84%
1.46%
5.21%
3.85%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 8.71% vs -7.01% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 478.95% vs 69.64% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 115.47% vs 101.86% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 8.06% vs 27.40% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of BrightGene Bio-Medical Technology Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
353.16
0
353.16
Other Operating Income
0.00
0.00
0.00
Total Operating income
353.16
0
353.16
Raw Material Cost
174.35
0
174.35
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
20.07
0
20.07
Selling and Distribution Expenses
54.16
0
54.16
Other Expenses
2.42
0.00
2.42
Total Expenditure (Excl Depreciation)
272.77
0
272.77
Operating Profit (PBDIT) excl Other Income
80.39
0.00
80.39
Other Income
5.57
0
5.57
Operating Profit (PBDIT)
122.59
0
122.59
Interest
20.07
0
20.07
Exceptional Items
16.14
0
16.14
Gross Profit (PBDT)
178.81
0
178.81
Depreciation
45.61
0
45.61
Profit Before Tax
73.05
0
73.05
Tax
9.49
0
9.49
Provisions and contingencies
0
0
0.00
Profit After Tax
49.64
0
49.64
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
49.64
0
49.64
Share in Profit of Associates
0
0
0.00
Minority Interest
5.34
0
5.34
Other related items
0.00
0.00
0.00
Consolidated Net Profit
54.98
0
54.98
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,052.33
0
3,052.33
Earnings per share (EPS)
0.11
0
0.11
Diluted Earnings per share
0.11
0
0.11
Operating Profit Margin (Excl OI)
20.22%
0%
0.00
20.22%
Gross Profit Margin
33.60%
0%
0.00
33.60%
PAT Margin
14.06%
0%
0.00
14.06%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 35.32 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 8.71% vs -7.01% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 22.43% vs -9.16% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.50 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 478.95% vs 69.64% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 773.02% vs -69.12% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.70 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 115.47% vs 101.86% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 97.30% vs 6.08% in Jun 2025
Quarterly - Interest
Interest 2.01 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 8.06% vs 27.40% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 42.55% vs 2.92% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.22%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
